A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Heart Failure With Preserved Ejection Fraction and Obesity (Summit
ClinicalTrials.gov NCT04847557
Research payments
$4,334,189
Through program year 2025, $4,334,189 in research payments was reported against A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Heart Failure With Preserved Ejection Fraction and Obesity (Summit, across 262 payments.
- Paid by (largest first)
- Eli Lilly and Company; Eli Lilly Export S.A. Puerto Rico Branch
- ClinicalTrials.gov
- NCT04847557
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $118,055 | 9 |
| 2024 | Research | $1,412,471 | 59 |
| 2022 | Research | $1,906,206 | 106 |
| 2021 | Research | $897,457 | 88 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Brittany Palmer Pittsburgh, PA Named on 7 payments
- Jay Amin Clearwater, FL Named on 5 payments
- Andrew Dewolfe Safety Harbor, FL Named on 5 payments
- Fahed Bitar Covina, CA Named on 5 payments
- Kaushik Jain Huntsville, AL Named on 5 payments
- Seth Baum Boca Raton, FL Named on 5 payments
- Sheldon Litwin Charleston, SC Named on 4 payments
- Ahmad Slim Tacoma, WA Named on 4 payments
- Norman Lepor Beverly Hills, CA Named on 4 payments
- Mehrdad Ariani Northridge, CA Named on 4 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.